Injection Pen Global Market Types and Applications, Drivers, Ongoing Trends, Future Demand, Challenges, Top Companies And Forecast 2024-2033 | Merck KGaA, AstraZeneca PLC, Wockhardt Ltd., AptarGroup Inc., Novartis AG

The injection pen market size has grown strongly in recent years. It will grow from $53.79 billion in 2023 to $58.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increase in need for diabetes management, increased patient preference, reduced needle phobia, improved dosage accuracy, increased aging population.

The injection pen market size is expected to see strong growth in the next few years. It will grow to $85.75 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to rising diabetes prevalence, rising biologics and biosimilars, rising need for personalized medicine, need for home healthcare, increasing emerging markets. Major trends in the forecast period include smart injection pens, digital health integration, wearable devices, improved user interface, autoinjector compatibility.

Market Overview -
Injection pens are used for injecting medication under the skin. Injection pens make injectable medicine such as insulin easier and more convenient to use, thus increasing patient adherence. The pens contain a cartridge, a dial to measure dosage, and a disposable needle and allow more simple, accurate, and convenient delivery than a vial and syringe.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=5676&type=smp

Rising Disease Prevalence Fuels Growth Of Injection Pen Market
The rise in the prevalence of diseases such as diabetes and arthritis are contributing to the growth of the injection pen market. Factors such as an increase in the size of the obese population, physical inactivity, unhealthy eating habits, and increasing age led to an increase in the global prevalence of diabetes. For instance, as per the International Diabetes Federation (IDF), the global diabetes prevalence population, by 2040, is expected to reach about 640 million. Furthermore, in the population of emerging countries such as India, about 69 million people are diabetic. By 2030, this number is expected to rise to 100 million. Therefore, the rise in the prevalence of diseases such as diabetes and arthritis will drive the growth of the injection pen market.

Competitive Landscape -
Major companies operating in the injection pen market include Novo Nordisk A/S, Ypsomed Holding AG, Sandoz Inc., Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford Ltd., Sulzer Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Ltd., Wockhardt Ltd., AptarGroup Inc., Novartis AG, Gerresheimer AG, SHL Medical AG, Boehringer Ingelheim International GmbH, Nemera France SA, Companion Medical Inc., Jiangsu Delfu Medical Devices Co. Ltd., Haselmeier GmbH, GlaxoSmithKline plc., Stat Medical Devices Inc., DuPont de Nemours Inc., Emperra GmbH E-Health Technologies, Biocon Limited, Becton Dickinson and Company, Mylan N.V., Terumo Corporation, West Pharmaceutical Services Inc., Bespak Europe Ltd., Mitsubishi Gas Chemical Company Inc., Nipro Corporation, Zogenix Inc., Consort Medical plc

Technological Advancements Transforming The Injection Pen Market
Technological advancements are a key trend gaining popularity in the injection pen market. Companies in the injection pen market are focusing on product innovations and efficient delivery systems. Technological advancements provide for accurate delivery, improved patient satisfaction and adherence, and greater ease of use. For instance, in September 2022, Medtronic, a US-based medical technology, services, and solutions company, launched InPen integrated with real-time1 Guardian Connect CGM data. This integrated solution gives users all the information they need to manage their diabetes in one screen, including real-time glucose levels and information on insulin dosing. Users may access all their information in real time, in one screen, rather than jumping between apps, making it simpler to decide how much medication to take to control their blood sugar levels.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report

Key Segments -
The injection pen market covered in this report is segmented -
1) By Product Type: Disposable Injection Pens, Reusable Injection Pens
2) By Therapy: Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, Other Therapies
3) By End Users: Home Care, Hospital & Clinics

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.